Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1016 |
---|---|
Product Name | Anti-Human CD52 Recombinant Antibody(Alemtuzumab) |
Molecular Name | Alemtuzumab |
Alias | Anti-CD52 Recombinant Antibody, Research Grade Alemtuzumab |
CAS Number | 216503-57-0 |
Molecular Weight | 150 kDa |
Target | CD52[Homo sapiens] |
Isotype | IgG1 Kappa |
Clonity | Monoclonal |
Host | Rabbit |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | FCM |
Buffer | PBS, pH7.5 |
Background | Alemtuzumab, sold under the brand names Campath and Lemtrada among others, is a medication used to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis.[1] In CLL, it has been used as both a first line and second line treatment.[ |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |